Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

327
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
327
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

205
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
205
Long-term Depression01:03

Long-term Depression

2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

323
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
323
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

162
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
162
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

121.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
121.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shared decision-making in ongoing psychotherapy: Negotiating frames, preferences and meaning.

Psychotherapy research : journal of the Society for Psychotherapy Research·2026
Same author

A systematic review of the prevalence of fatigue in common mental disorders (mood disorders, anxiety disorders, personality disorders, and trauma and stressor related disorders).

BMC psychiatry·2026
Same author

Virtual Reality-Based Avatar Intervention for Eating Disorders: Mixed Methods Feasibility Study.

JMIR formative research·2026
Same author

The danish version of patient reported outcomes measurement information system depression and anxiety short-forms (PROMIS-D-SF 6a and PROMIS-A-SF 6a) are promising tools to screen for anxiety and depression.

BMC psychiatry·2026
Same author

Evaluating ICD-11 anorexia nervosa in a clinical youth sample: a comparison with ICD-10.

European child & adolescent psychiatry·2026
Same author

Latent Trajectories of Body Mass Index and Depressive Symptoms in Inpatients With Anorexia Nervosa: Predictors and Outcomes.

The International journal of eating disorders·2026

Related Experiment Video

Updated: Sep 4, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

781

Patient-reported outcome measures in depression.

Dávid Húsdal Á Steig1, Nina Reinholt2, Anne Bryde Christensen2

  • 1Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Nordic Journal of Psychiatry
|July 18, 2022
PubMed
Summary
This summary is machine-generated.

Jacobson plots show that cognitive behavior therapy (CBT) group interventions effectively treat moderate depression. However, severe depression and functional impairment recovery rates were lower than expected in mental health services.

Keywords:
Jacobson plotMajor depressive disordercase-nesscognitive behavioral therapyoutpatientsquality assurancerecovery

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.0K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.7K

Related Experiment Videos

Last Updated: Sep 4, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

781
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.0K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.7K

Area of Science:

  • Psychiatry and Mental Health
  • Clinical Psychology
  • Health Services Research

Background:

  • Patient-reported outcome measures (PROMs) are crucial for quality assurance in mental health services (MHS).
  • Jacobson plots offer a feasible method for estimating recovery rates from clinical data.
  • This study applies Jacobson plots to assess recovery in group psychotherapy settings.

Purpose of the Study:

  • To evaluate recovery rates in patients undergoing group psychotherapy using Jacobson plots.
  • To determine if recovery rates exceed 50% and identify factors influencing outcomes.
  • To specifically examine recovery rates in patients with severe depression.

Main Methods:

  • A secondary analysis of data from a randomized controlled trial involving 171 patients with unipolar depression.
  • Patients received 14 weekly group cognitive behavior therapy (CBT) sessions.
  • Depression (Beck Depression Inventory-II) and functional (Work and Social Adjustment Scale) PROMs were collected at baseline, end-of-treatment, and 6-month follow-up.

Main Results:

  • At 6-month follow-up, 35% of patients with moderate/severe depression at baseline achieved scores below the moderate depression cut-off.
  • Recovery rates were significantly lower for severe depression cases (26.5%) compared to moderate cases (52.5%).
  • Severe functional impairment was present in 36% of patients, with 44% showing no improvement or worsening at follow-up.

Conclusions:

  • Group CBT achieved satisfactory remission rates for patients with moderate depression.
  • Recovery rates for patients with severe depression and functional impairment fell below the standards of comparable mental health services.
  • There is a need for improved mental health services tailored to patients with severe depression and functional impairment.